Octagon Capital Advisors LP Bridge Bio Pharma, Inc. Transaction History

Octagon Capital Advisors LP

$449 Million
Q4 2024

A detailed history of Octagon Capital Advisors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 441,600 shares of BBIO stock, worth $16.3 Million. This represents 2.7% of its overall portfolio holdings.

Number of Shares

441,600

Previous 552,000 20.0%

Holding current value

$16.3 Million

Previous $14.1 Million 13.78%

% of portfolio

2.7%

Previous 3.39%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$22.35 - $29.5 $2.47 Million - $3.26 Million	-110,400 Reduced 20.0%	441,600 $12.1 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $3.3 Million - $4.32 Million	-138,000 Reduced 20.0%	552,000 $14.1 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $459,480 - $679,560	-16,800 Reduced 2.38%	690,000 $21.3 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $12.3 Million - $22.5 Million	-512,400 Reduced 42.03%	706,800 $28.5 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $1.58 Million - $2.14 Million	-118,960 Reduced 8.89%	1,219,200 $21 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $2.9 Million - $7.5 Million	404,417 Added 43.31%	1,338,160 $22.2 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $6.95 Million - $16.2 Million	-1,333,743 Reduced 58.82%	933,743 $8.48 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $3.67 Million - $8.58 Million	500,000 Added 28.29%	2,267,486 $23 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $13.6 Million - $64 Million	1,198,072 Added 210.4%	1,767,486 $29.5 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $8.83 Million - $12.1 Million	188,486 Added 49.48%	569,414 $26.7 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $17.7 Million - $24.4 Million	380,928 New	380,928 $23.2 Million

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.46B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Account

Octagon Capital Advisors LP Bridge Bio Pharma, Inc. Transaction History